z-logo
Premium
2‐Furoyl‐LIGRL‐NH 2 , a potent agonist for proteinase‐activated receptor‐2, as a gastric mucosal cytoprotective agent in mice
Author(s) -
Kawabata Atsufumi,
Oono Yuko,
Yonezawa Daiki,
Hiramatsu Kaori,
Inoi Naoki,
Sekiguchi Fumiko,
Honjo Masami,
Hirofuchi Michiko,
Kanke Toru,
Ishiwata Hiroyuki
Publication year - 2005
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0706059
Subject(s) - capsaicin , agonist , pharmacology , oral administration , receptor , medicine , knockout mouse , potency , endocrinology , chemistry , biochemistry , in vitro
1 Proteinase‐activated receptor‐2 (PAR 2 ), expressed in capsaicin‐sensitive sensory neurons, plays a protective role in gastric mucosa. The present study evaluated gastric mucosal cytoprotective effect of 2‐furoyl‐LIGRL‐NH 2 , a novel highly potent PAR 2 agonist, in ddY mice and in wild‐type and PAR 2 ‐knockout mice of C57BL/6 background. 2 Gastric mucosal injury was created by oral administration of HCl/ethanol solution in the mice. The native PAR 2 ‐activating peptide SLIGRL‐NH 2 , administered intraperitoneally (i.p.) at 0.3–1  μ mol kg −1 in combination with amastatin, an aminopeptidase inhibitor, but not alone, revealed gastric mucosal protection in ddY mice, which was abolished by ablation of capsaicin‐sensitive sensory neurons. 3 I.p. administration of 2‐furoyl‐LIGRL‐NH 2 at 0.1  μ mol kg −1 , without combined treatment with amastatin, exhibited gastric mucosal cytoprotective activity in ddY mice, the potency being much greater than SLIGRL‐NH 2 in combination with amastatin. This effect was also inhibited by capsaicin pretreatment. 4 Oral administration of 2‐furoyl‐LIGRL‐NH 2 at 0.003–0.03  μ mol kg −1 also protected against gastric mucosal lesion in a capsaicin‐reversible manner in ddY mice. 5 I.p. 2‐furoyl‐LIGRL‐NH 2 at 0.1–0.3  μ mol kg −1 caused prompt salivation in anesthetized mice, whereas its oral administration at 0.003–1  μ mol kg −1 was incapable of eliciting salivation. 6 In wild‐type, but not PAR 2 ‐knockout, mice of C57BL/6 background, i.p. administration of 2‐furoyl‐LIGRL‐NH 2 caused gastric mucosal protection. 7 Thus, 2‐furoyl‐LIGRL‐NH 2 is considered a potent and orally available gastric mucosal protective agent. Our data also substantiate a role for PAR 2 in gastric mucosal protection and the selective nature of 2‐furoyl‐LIGRL‐NH 2 .British Journal of Pharmacology (2005) 144 , 212–219. doi: 10.1038/sj.bjp.0706059

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom